Comparative Pharmacology
Head-to-head clinical analysis: AMMONIUM CHLORIDE 2 14 versus SILPHEN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMMONIUM CHLORIDE 2 14 versus SILPHEN.
AMMONIUM CHLORIDE 2.14% vs SILPHEN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ammonium chloride is an acidifying agent. It dissociates into ammonium and chloride ions. The ammonium ion is metabolized in the liver to urea and hydrogen ions, leading to metabolic acidosis. This reduces blood pH and increases renal excretion of alkaline urine.
N-acetyl-para-aminophenol (APAP) is a centrally and peripherally acting analgesic and antipyretic. Its mechanism involves inhibition of cyclooxygenase (COX) in the central nervous system, reducing prostaglandin synthesis, and activation of descending serotonergic pathways. It does not significantly inhibit peripheral COX or platelet function.
For metabolic alkalosis: 1.5 to 3 g (approximately 280 to 560 mEq) intravenously over 4 to 6 hours; adjust based on serum chloride and pH.
1-2 tablets (25-50 mg diphenhydramine HCl) orally every 4-6 hours as needed; maximum 300 mg/day.
None Documented
None Documented
4-6 hours; prolonged in renal impairment (up to 12-15 hours).
Terminal elimination half-life is 4-6 hours in patients with normal renal function; prolongs to 12-24 hours with creatinine clearance <30 mL/min.
Renal: >99% as ammonium ion and chloride; minimal biliary/fecal elimination.
Renal excretion accounts for 65% of the dose as unchanged drug; hepatic metabolism produces inactive glucuronide conjugates (20%), with biliary/fecal elimination comprising the remaining 15%.
Category C
Category C
Expectorant/Systemic Acidifier
Expectorant